0001610618-23-000034.txt : 20230329 0001610618-23-000034.hdr.sgml : 20230329 20230329173023 ACCESSION NUMBER: 0001610618-23-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230327 FILED AS OF DATE: 20230329 DATE AS OF CHANGE: 20230329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stein Jeffrey CENTRAL INDEX KEY: 0001478831 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 23776324 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE, SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 4 1 wf-form4_168012541068205.xml FORM 4 X0407 4 2023-03-27 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001478831 Stein Jeffrey 6310 NANCY RIDGE DRIVE, STE 101 SAN DIEGO CA 92121 1 1 0 0 President & CEO 0 Common Stock 2023-03-27 4 A 0 271750 0 A 1202385 D Common Stock 281602 I By trust Common Stock 42009 I By son Employee Stock Option (right to buy) 1.01 2023-03-27 4 A 0 543500 0 A 2033-03-26 Common Stock 543500.0 543500 D Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date. Includes 8,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on May 20, 2022 and November 18, 2022. The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023. /s/ Shane Ward, Attorney-in-Fact 2023-03-29